Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
Jonathan J. Keats, Rafaël Fonseca, Marta Chesi et al. · Cancer Cell · 2007
Cited by 981 works. doi:10.1016/j.ccr.2007.07.003 Open-access PDF
Authors
- Jonathan J. Keats
- Rafaël Fonseca
- Marta Chesi
- Roelandt F.J. Schop
- Angela S. Baker
- Wee Joo Chng
- Scott Van Wier
- Rodger Edwin Tiedemann
- Chang-Xin Shi
- Michaël Sébag
- Esteban Braggio
- Travis J. Henry
- Yuan-Xiao Zhu
- Homer W. Fogle
- Tammy L. Price-Troska
- Gregory J. Ahmann
- Catherine M. Mancini
- Leslie A. Brents
- Shaji Kunnathu Kumar
- Philip R. Greipp
References
- Global variation in copy number in the human genome
- A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
- Circular binary segmentation for the analysis of array-based DNA copy number data
- Nuclear factor-κB in cancer development and progression
- B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50
- Identification and Validation of Oncogenes in Liver Cancer Using an Integrative Oncogenomic Approach
- Multiple myeloma: evolving genetic events and host interactions
- Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-κb-inducing kinase
- Clinical and biologic implications of recurrent genomic aberrations in myeloma
- Mice Deficient in Nuclear Factor (NF)-κB/p52 Present with Defects in Humoral Responses, Germinal Center Reactions, and Splenic Microarchitecture